🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SP942 is a non-interventional post-authorization safety study (PASS) to eva...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00771927
Treatments Being Tested
EP0060 is a multicenter, open-label study to evaluate the safety and tolera...
Status
Completed
Location
Ep0060 003
Start Date
2017-05-30
Trial ID
NCT02710890
Treatments Being Tested
The purpose of the trial is to evaluate the safety of intravenous (iv) laco...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00655551
Treatments Being Tested
Trial to determine if seizure prophylaxis with IV LCM in NSICU patients exp...
Status
Terminated
Location
UC Health University Pointe
Start Date
2010-05
Trial ID
NCT01110187
Treatments Being Tested
The purpose of this study is to evaluate the safety of IV Lacosamide in chi...
Status
Completed
Location
Lebonheur Children's Hospital
Start Date
2010-04
Trial ID
NCT01981447
Treatments Being Tested
To evaluate the safety of IV Lacosamide in children with partial-onset epil...
Status
Completed
Location
LeBonheur Children's Medical Center
Start Date
2010-03
Trial ID
NCT00832884
Treatments Being Tested
The purpose of this study is to evaluate the effect of different intravenou...
Status
Terminated
Location
Foothills Medical Center
Start Date
2013-05
Trial ID
NCT01724918
Treatments Being Tested
This study will be conducted to compare the pharmacokinetics of Lacosamide ...
Status
Completed
Location
001
Start Date
2013-11
Trial ID
NCT01986608
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of lacosamide (LCM) ve...
Status
Terminated
Location
Sp0968 101
Start Date
2021-03-31
Trial ID
NCT04519645
Treatments Being Tested
Primary Objective: Null hypothesis: A 24-week trial of adjunctive Lacosami...
Status
Completed
Location
Northeast Regional Epilepsy Group
Start Date
2010-05
Trial ID
NCT01175954
Treatments Being Tested